📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
9 articles
AVG GRADE
HIGH
score: 0.89
SENTIMENT
BULLISH
TOTAL VIEWS
20
RGEN Stock Analysis & AI Grade: HIGH
9 articles analyzed · Sentiment: BULLISH · AI-powered equity research
RECENT COVERAGE · 9 ARTICLES
Repligen: Acquisition To Add Cell Therapy Capabilities (NASDAQ:RGEN)
RGEN announced a $1.5B acquisition of BioLife Solutions, a strategic move designed to expand its footprint in the high-growth cell...
Leaving Estimates in the Dust: 28 Firms Beating Earnings Expectations
The broader S&P 500 achieved a 6% median EPS surprise in Q1 2026, marking the strongest earnings beat cycle in four years and...
Repligen Q2 2026 Earnings Preview (NASDAQ:RGEN)
Repligen (RGEN) is scheduled to report Q2 2026 earnings in premarket trading on July 28, creating a near-term event catalyst for the...
Repligen Corporation (RGEN) M&A Call Transcript
RGEN's M&A announcement signals a transformative capital deployment event for the bioprocessing and life sciences tools sector. Merger...
Repligen Corporation (RGEN) BioLife Solutions, Inc., - M&A Call - Slideshow (NASDAQ:RGEN) 2026-07-23
Repligen Corporation (RGEN) initiated a merger and acquisition call regarding BioLife Solutions, Inc. (BLFS), signaling consolidation...
BioLife Solutions Stock Gains 6% After Agreeing To $1.5 Bln Acquisition Deal
BioLife Solutions (BLFS) announced a $1.5 billion acquisition by Repligen Corporation (RGEN), triggering immediate upside momentum in...
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
Repligen's (RGEN) acquisition of BioLife Solutions (BLFS) represents a significant consolidation play in the high-margin biopreservation...
Repligen to buy BioLife Solutions in $1.5B stock-and-cash deal
Repligen announced a $1.5 billion acquisition of BioLife Solutions, combining two critical players in bioprocess solutions and cell...
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
Repligen's acquisition of BioLife Solutions represents a strategic consolidation in the biopreservation and cell therapy space,...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice